AVB vs MRSN · P/E 23, rev $3.04B vs rev $40.5M
AvalonBay Communities Inc (AVB) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the AVB and MRSN stock pages for the full models.
Not investment advice.